The FDA has approved Axsome Therapeutics’ Auvelity for major depressive disorder (MDD) in adults, making it the first and only oral N-methyl D-aspartate (NMDA) receptor antagonist approved for this indication.
If you are not happy with the results below please do another search
50 search results for:
Copenhagen-based Lundbeck revealed Wednesday that its migraine drug Vyepti (eptinezumab) failed to demonstrate statistical superiority over placebo at reducing the number of monthly migraine days.
Researchers studying Alzheimer’s disease have published new studies supporting links between Alzheimer’s and other diseases, as well as potential risk factors for developing the disease later in life.
South Korea-based Genuv Inc. announced the publication of a preclinical study showing that Mekinist (trametinib), approved by the FDA for melanoma, has a neuroprotective effect in Alzheimer’s disease.
The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had “revolutionized” the treatment of a disease once seen as a near-certain killer.
North Korean leader Kim Jong Un held a ceremony to thank and praise military medics for spearheading the country’s fight against the coronavirus in the capital Pyongyang, state media said on Friday.
A manufacturer of the drug used in medication abortions on Thursday dropped its bid to sell mifepristone in Mississippi despite the state’s recently enacted abortion ban.
Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manufacturer to package its Jynneos monkeypox vaccine and the production is expected to begin later this year.
Three healthcare agencies have once again found themselves on the Inc. 5000 list in 2022 – CrowdPharm; Peregrine Market Access; and Rare Patient Voice. The Inc. 5000 ranks the nation’s fastest-growing private companies.
The World Health Organization (WHO) on Thursday recommended the use of French drugmaker Valneva’s COVID-19 vaccine.